A new article on the role of screening hepatitis C has been published in Hepatitic Medicine: Evidence and Research, co-authored by Andrew Reynolds, Project Inform’s Hepatitis C Education Manager. Read the full article here.
Project Inform will host the upcoming webinar: Scaling Up Risk Based Hepatitis C Screening in the US, presented by Andrew Reynolds, Hepatitis C Education Manager for Project Inform. Wednesday July 23, 2014 1:00–2:00pm EST Sign up for the webinar WEBINAR DESCRIPTION: With over 5 million people chronically…Read More
The development of the HIV treatment cascade has been a valuable tool to help clinicians, public health officials and advocates visualize the state of HIV testing, linkage to care and treatment. In recent months, we have now seen the development of a hepatitis C treatment cascade….Read More
Project Inform is very pleased to announce the 2014 Hepatitis C Drug Guide, published by Positively Aware, a bi-monthly publication from Test Positive Aware Network in Chicago. Get the latest in treatment information for hepatitis C in mono-infected and co-infected people.
Join or Support Team Project Inform for AIDS Walk 2014 and help us create a generation free of HIV! As the lead beneficiary, your support of Project Inform benefits not only our lifesaving education and advocacy work, but the work of many other vital AIDS Service…Read More
Hepatitis C (HCV) is an important health issue in the United States and abroad. As a blood-borne infection, HCV is most commonly transmitted from sharing injection drug equipment. However, transmission from mother to child (MTC) during pregnancy and/or childbirth — also referred to as vertical transmission…Read More
In a statement released today, Boehringer Ingelheim (BI) has decided not to move forward with any approvals or marketing considerations for their protease inhibitor, faldaprevir. This move comes as HCV treatments are rapidly evolving to all-oral treatment with fewer side effects and high SVR (cure) rates….Read More